KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Evolent Health (EVH) FCF Payout Ratio (2020 - 2025)

Evolent Health has reported FCF Payout Ratio over the past 6 years, most recently at 0.28 for Q3 2025.

  • For Q3 2025, FCF Payout Ratio fell 32.09% year-over-year to 0.28; the TTM value through Dec 2025 reached 2.34, up 171.4%, while the annual FY2025 figure was 2.34, 171.4% up from the prior year.
  • FCF Payout Ratio for Q3 2025 was 0.28 at Evolent Health, up from 0.12 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 3.36 in Q2 2022 and troughed at 11.59 in Q1 2024.
  • A 5-year average of 0.73 and a median of 0.04 in 2021 define the central range for FCF Payout Ratio.
  • Biggest five-year swings in FCF Payout Ratio: soared 7809.87% in 2022 and later plummeted 5307.49% in 2024.
  • Year by year, FCF Payout Ratio stood at 0.04 in 2021, then soared by 7809.87% to 3.36 in 2022, then plummeted by 98.16% to 0.06 in 2023, then tumbled by 339.58% to 0.15 in 2024, then skyrocketed by 289.74% to 0.28 in 2025.
  • Business Quant data shows FCF Payout Ratio for EVH at 0.28 in Q3 2025, 0.12 in Q2 2025, and 1.14 in Q1 2025.